PUL-042

· Pulmotect, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PUL-042, covering 2017-08-10 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) [Phase 2]

See pricing